This is in keeping with our previous reports of mismatch cases in ALS, and mismatch cases that exist for other neurodegenerative diseases, in which TDP-43 burden is not related to clinical manifestations of dysfunction in those brain regions (4). Here, TARDBP is linked to neurodegenerative disease.